Literature DB >> 31793053

Endothelial-platelet interactions in influenza-induced pneumonia: A potential therapeutic target.

Marcel G E Rommel1, Christian Milde1, Regina Eberle2, Harald Schulze3, Ute Modlich1.   

Abstract

Every year, influenza viruses spread around the world, infecting the respiratory systems of countless humans and animals, causing illness and even death. Severe influenza infection is associated with pulmonary epithelial damage and endothelial dysfunction leading to acute lung injury (ALI). There is evidence that an aggressive cytokine storm and cell damage in lung capillaries as well as endothelial/platelet interactions contribute to vascular leakage, pro-thrombotic milieu and infiltration of immune effector cells. To date, treatments for ALI caused by influenza are limited to antiviral drugs, active ventilation or further symptomatic treatments. In this review, we summarize the mechanisms of influenza-mediated pathogenesis, permissive animal models and histopathological changes of lung tissue in both mice and men and compare it with histological and electron microscopic data from our own group. We highlight the molecular and cellular interactions between pulmonary endothelium and platelets in homeostasis and influenza-induced pathogenesis. Finally, we discuss novel therapeutic targets on platelets/endothelial interaction to reduce or resolve ALI.
© 2019 The Authors. Anatomia, Histologia, Embryologia Published by Blackwell Verlag GmbH.

Entities:  

Keywords:  endothelial cell; influenza; interaction; laboratory animals; lung injury; platelet; pneumonia; therapy

Year:  2019        PMID: 31793053     DOI: 10.1111/ahe.12521

Source DB:  PubMed          Journal:  Anat Histol Embryol        ISSN: 0340-2096            Impact factor:   1.114


  6 in total

1.  Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation.

Authors:  Douglas D Fraser; Eric K Patterson; Marat Slessarev; Sean E Gill; Claudio Martin; Mark Daley; Michael R Miller; Maitray A Patel; Claudia C Dos Santos; Karen J Bosma; David B O'Gorman; Gediminas Cepinskas
Journal:  Crit Care Explor       Date:  2020-08-24

2.  Association between plasma glycocalyx component levels and poor prognosis in severe influenza type A (H1N1).

Authors:  Xiao Huang; Feng Lu; Huanhuan Tian; Haoran Hu; Fangyu Ning; Quanmei Shang; Dong Hao; Weiwei Zhu; Guiqing Kong; Xiaohong Ma; Jiali Feng; Tao Wang; Xiaozhi Wang
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.996

Review 3.  Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.

Authors:  David G Menter; Vahid Afshar-Kharghan; John Paul Shen; Stephanie L Martch; Anirban Maitra; Scott Kopetz; Kenneth V Honn; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2022-01-12       Impact factor: 9.237

4.  Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.

Authors:  Feng Pan; Lian Yang; Yuncheng Li; Bo Liang; Lin Li; Tianhe Ye; Lingli Li; Dehan Liu; Shan Gui; Yu Hu; Chuansheng Zheng
Journal:  Int J Med Sci       Date:  2020-05-18       Impact factor: 3.738

5.  Evaluation of organ function in patients with severe COVID-19 infections.

Authors:  Yingjie Zhu; Ziqiang Du; Yanfang Zhu; Wenfeng Li; Hongjun Miao; Zhuo Li
Journal:  Med Clin (Engl Ed)       Date:  2020-09-19

Review 6.  Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target.

Authors:  Nadia Alice Vieira Motta; Lis Jappour Autran; Stephani Correia Brazão; Rosane de Oliveira Lopes; Christianne Brêtas Vieira Scaramello; Gabriel Ferreira Lima; Fernanda Carla Ferreira de Brito
Journal:  Int Immunopharmacol       Date:  2020-12-28       Impact factor: 5.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.